Aligning with these observations, our RNA sequencing and GSEA analyses identified deregulated TNF‐α, PI3K‐AKT, AGER, and endothelial barrier signaling pathways, and revealed disruptions in metabolic, inflammatory, and vascular networks in DM lungs. The gene discussed is AKT1; the disease is diabetes mellitus.